16 results
424B5
STRO
Sutro Biopharma Inc
2 Apr 24
Prospectus supplement for primary offering
4:58pm
, and, if necessary, seek expert advice on those matters.
S-19
Notice to Prospective Investors in Hong Kong
The shares have not been offered or sold
PRE 14A
STRO
Sutro Biopharma Inc
14 Apr 23
Preliminary proxy
4:05pm
Committee is financially literate. In addition, our Board of Directors has determined that Ms. Hunter is an “Audit Committee financial expert
DEF 14A
ba3ca48k 0f7xq0igfld
26 Apr 19
Definitive proxy
12:00am
10-K
EX-3.2
xyuy 2dctk
1 Apr 19
Annual report
12:00am
10-Q
EX-3.2
k4n4jpw ey8y
14 Nov 18
Quarterly report
12:00am
DRS/A
n9sp e523z6rv6kv5gt
10 Jul 18
Draft registration statement (amended)
12:00am
DRS
xuszjlnohg8jby8wg
1 Jun 18
Draft registration statement
12:00am
DRS
EX-10.9
61vmwee
1 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next